Alamar Biosciences (ALMR) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
ALMR jumps 8.1% to $27.42 on 2.5x normal volume. Closed at $27.42, +8.08% vs the prior close of $25.37. Day range $25.11–$28.35, opened at $25.14.
ALMR daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — ALMR jumps 8.1% to $27.42 on 2.5x normal volume
- Closed at $27.42, +8.08% vs the prior close of $25.37. Day range $25.11–$28.35, opened at $25.14.
- Volume was 1.26M shares, 2.5x its 50-day average of 510.63K — unusually heavy trading.
- Price is -11.8% vs its 50-day average ($31.10).
- 52-week range $18.85–$39.61; today's close sits at 41% of that range, 30.8% below the 52-week high.
Oct 14, 2026 — ALMR jumps 7.9% to $25.37
- Closed at $25.37, +7.87% vs the prior close of $23.52. Day range $22.98–$25.66, opened at $23.19.
- Volume was 467.00K shares, 0.9x its 50-day average of 506.74K.
- Price is -18.5% vs its 50-day average ($31.12).
- 52-week range $18.85–$39.61; today's close sits at 31% of that range, 36.0% below the 52-week high.
Oct 13, 2026 — ALMR dips 3.0% to $23.52, a 3-month low, 6 down days in a row
- Closed at $23.52, -2.97% vs the prior close of $24.24. Day range $23.29–$24.28, opened at $23.89.
- Volume was 755.90K shares, 1.5x its 50-day average of 495.30K.
- Price is -24.5% vs its 50-day average ($31.16).
- 52-week range $18.85–$39.61; today's close sits at 22% of that range, 40.6% below the 52-week high.
- That makes 6 straight losses.
Oct 12, 2026 — ALMR slides 4.1% to $24.24, a 1-month low on 2.1x normal volume
- Closed at $24.24, -4.08% vs the prior close of $25.27. Day range $23.57–$26.70, opened at $25.07.
- Volume was 1.03M shares, 2.1x its 50-day average of 477.85K — unusually heavy trading.
- Price is -22.4% vs its 50-day average ($31.23).
- 52-week range $18.85–$39.61; today's close sits at 26% of that range, 38.8% below the 52-week high.
- That makes 5 straight losses.
Oct 9, 2026 — ALMR dips 2.5% to $25.27, a 1-month low on 2.5x normal volume
- Closed at $25.27, -2.47% vs the prior close of $25.91. Day range $24.23–$26.60, opened at $25.97.
- Volume was 1.13M shares, 2.5x its 50-day average of 458.04K — unusually heavy trading.
- Price is -19.1% vs its 50-day average ($31.25).
- 52-week range $18.85–$39.61; today's close sits at 31% of that range, 36.2% below the 52-week high.
- That makes 4 straight losses.
Oct 8, 2026 — ALMR slides 6.7% to $25.91, a 1-month low on 2.1x normal volume
- Closed at $25.91, -6.70% vs the prior close of $27.77. Day range $25.37–$28.07, opened at $28.05.
- Volume was 955.50K shares, 2.1x its 50-day average of 444.83K — unusually heavy trading.
- Price is -17.1% vs its 50-day average ($31.24).
- 52-week range $18.85–$39.61; today's close sits at 34% of that range, 34.6% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — ALMR slides 13.9% to $27.77 on 2.7x normal volume
- Closed at $27.77, -13.92% vs the prior close of $32.26. Day range $27.76–$32.02, opened at $31.65.
- Volume was 1.15M shares, 2.7x its 50-day average of 425.68K — unusually heavy trading.
- Price is -11.0% vs its 50-day average ($31.21).
- 52-week range $18.85–$39.61; today's close sits at 43% of that range, 29.9% below the 52-week high.
Oct 6, 2026 — ALMR slides 15.4% to $32.26 on 3.9x normal volume
- Closed at $32.26, -15.39% vs the prior close of $38.13. Day range $31.13–$39.61, opened at $38.74.
- Volume was 1.55M shares, 3.9x its 50-day average of 398.25K — unusually heavy trading.
- Price is +3.6% vs its 50-day average ($31.15).
- 52-week range $18.85–$39.61; today's close sits at 65% of that range, 18.6% below the 52-week high.
Oct 5, 2026 — ALMR jumps 11.0% to $38.13, a 6-month high
- Closed at $38.13, +10.97% vs the prior close of $34.36. Day range $33.36–$38.38, opened at $34.66.
- Volume was 570.80K shares, 1.5x its 50-day average of 391.76K.
- Price is +23.0% vs its 50-day average ($31.00).
- 52-week range $18.85–$38.54; today's close sits at 98% of that range, 1.1% below the 52-week high.
Oct 2, 2026 — ALMR jumps 5.9% to $34.36
- Closed at $34.36, +5.85% vs the prior close of $32.46. Day range $32.80–$34.62, opened at $32.97.
- Volume was 339.90K shares, 0.9x its 50-day average of 387.67K.
- Price is +11.7% vs its 50-day average ($30.75).
- 52-week range $18.85–$38.54; today's close sits at 79% of that range, 10.8% below the 52-week high.
ALMR latest news & SEC filings
Every SEC filing by or about ALMR in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Oct 14, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Oct 14, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Oct 14, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 16, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Brottem John L. received an award of 29,000 shares on Sep 14, 2026; now holds 29,000
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 16, 2026 · 3 — Initial insider ownership statement (Form 3)
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Sep 1, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 13, 2026 · SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 11, 2026 · SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 11, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $29.43M (prior year $16.16M) (+82.1% vs Jun 30, 2025)
- Net income: -$13.20M (prior year -$7.02M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.22 (prior year -$0.62) (loss narrowed vs Jun 30, 2025)
Aug 10, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 15, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 7, 2026 · SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 2, 2026 · SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade ALMR
- Last results release: Aug 10, 2026 (8-K Item 2.02). Previous ones: May 8, 2026. Based on that rhythm, the next report is likely around Nov 9, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 5.52% (largest 15.4%). That is a volatile stock.
- Liquidity: about 795.97K shares (≈$21.83M) trade per day on average.
- 52-week position: $27.42 vs a range of $18.85–$39.61 (41% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 6 open-market buys, 0 sales; latest: Nicholas Naclerio bought 235,294 shares on Apr 20, 2026.
- Latest filings: 8-K Sep 1, 2026; 10-Q Aug 11, 2026; 8-K Aug 10, 2026.
- Listing: Nasdaq · industry: Laboratory Analytical Instruments.
ALMR market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 25.14 | 28.35 | 25.11 | 27.42 | 1.26M |
| Oct 14, 2026 | 23.19 | 25.66 | 22.98 | 25.37 | 467.00K |
| Oct 13, 2026 | 23.89 | 24.28 | 23.29 | 23.52 | 755.90K |
| Oct 12, 2026 | 25.07 | 26.70 | 23.57 | 24.24 | 1.03M |
| Oct 9, 2026 | 25.97 | 26.60 | 24.23 | 25.27 | 1.13M |
| Oct 8, 2026 | 28.05 | 28.07 | 25.37 | 25.91 | 955.50K |
| Oct 7, 2026 | 31.65 | 32.02 | 27.76 | 27.77 | 1.15M |
| Oct 6, 2026 | 38.74 | 39.61 | 31.13 | 32.26 | 1.55M |
| Oct 5, 2026 | 34.66 | 38.38 | 33.36 | 38.13 | 570.80K |
| Oct 2, 2026 | 32.97 | 34.62 | 32.80 | 34.36 | 339.90K |
| Oct 1, 2026 | 33.92 | 34.67 | 32.37 | 32.46 | 379.00K |
| Sep 30, 2026 | 32.47 | 35.28 | 32.24 | 34.07 | 741.80K |
| Sep 29, 2026 | 32.43 | 33.60 | 32.18 | 32.65 | 1.09M |
| Sep 28, 2026 | 32.71 | 33.17 | 31.94 | 32.61 | 224.70K |
| Sep 25, 2026 | 33.40 | 33.97 | 32.60 | 32.80 | 297.10K |
| Sep 24, 2026 | 32.15 | 33.71 | 31.68 | 33.20 | 527.30K |
| Sep 23, 2026 | 33.22 | 33.68 | 32.06 | 32.14 | 353.10K |
| Sep 22, 2026 | 34.83 | 35.49 | 32.52 | 33.22 | 455.10K |
| Sep 21, 2026 | 35.20 | 35.66 | 33.93 | 35.05 | 614.50K |
| Sep 18, 2026 | 31.76 | 37.76 | 31.76 | 34.85 | 2.03M |
About Alamar Biosciences
Alamar Biosciences (ALMR) is listed on the Nasdaq and classified by the SEC under “Laboratory Analytical Instruments”. Its business address is in FREMONT, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 2104204.
ALMR board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Rebecca Chambers | Director | Apr 20, 2026 |
| Shiping Chen | Chief Operating Officer | Apr 20, 2026 |
| Yuling Luo | Chief Executive Officer | Apr 20, 2026 |
| Nicholas Naclerio | Director | Apr 20, 2026 |
| Robert P Ragusa | Director | Sep 3, 2026 |
| Ian W Ratcliffe | Director | Apr 16, 2026 |
| Frank Witney | Director | Apr 20, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| John L. Brottem | General Counsel | Sep 16, 2026 |
| Shiping Chen | Chief Operating Officer | Apr 20, 2026 |
| Yuling Luo | Chief Executive Officer | Apr 20, 2026 |
| Justin J. Mcanear | Chief Financial Officer | Apr 20, 2026 |
| Timothy Ogden White | President | Apr 20, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Apr 20, 2026 | Nicholas Naclerio | Buy | 235,294 | $17.00 |
| Apr 20, 2026 | Innovation Fund Ii Gp, L.L.C. Illumina | Buy | 235,294 | $17.00 |
| Apr 20, 2026 | Innovation Fund Ii, L.P. Illumina | Buy | 235,294 | $17.00 |
| Apr 20, 2026 | Innovation Fund Iii Gp, L.L.C. Illumina | Buy | 235,294 | $17.00 |
| Apr 20, 2026 | Innovation Fund Iii, L.P. Illumina | Buy | 235,294 | $17.00 |
| Apr 20, 2026 | Nicholas Naclerio | Buy | 235,294 | $17.00 |
ALMR financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $390.98M, total liabilities $78.12M, cash $132.97M (as of Jun 30, 2026).
ALMR earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 10, 2026 | 8-K Item 2.02 (results) | $27.99 |
| May 8, 2026 | 8-K Item 2.02 (results) | $23.96 |
Related stocks · Laboratory Analytical Instruments
Illumina (ILMN)Waters (WAT)Mettler Toledo International Inc/ (MTD)Revvity (RVTY)Agilent Technologies (A)10x Genomics (TXG)Bruker (BRKR)Avantor (AVTR)Bio-Rad Laboratories (BIO)Pacific Biosciences Of California (PACB)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on ALMR
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.